Clinical Trial Update: EMD 121974 in Treating Patients With Progressive or Recurrent Glioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for EMD 121974 in progressive or recurrent glioma; the Phase 1/2 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• EMD 121974

Snippet

Sponsor: New Approaches to Brain Tumor Therapy Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED